The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 9,451 | 90,215 | SH | SOLE | 90,215 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 129,963 | 4,867,530 | SH | SOLE | 4,867,530 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 8,632 | 323,307 | SH | OTR | 1 | 0 | 323,307 | 0 | |
| LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 77,548 | 2,872,130 | SH | SOLE | 2,872,130 | 0 | 0 | ||
| MERRIMACK PHARMACEUTICALS INC | NOTE 4.5% 7/15/20 | 590328AA8 | 5,027 | 3,500,000 | PRN | SOLE | 3,500,000 | 0 | 0 | ||
| OPKO HEALTH INC | DEBT 3.0% 2/1/33 | 68375NAB9 | 21,399 | 14,000,000 | PRN | SOLE | 14,000,000 | 0 | 0 | ||